Related Experiment Video
Updated: Jan 3, 2026
Intravenous and Intra-amniotic In Utero Transplantation in the Murine Model
Published on: October 9, 2018
In utero Hepatitis B Immunization during Fetal Surgery for Spina Bifida
Ueli Moehrlen1,2,3, Julia Elrod1,3, Nicole Ochsenbein-Kölble2,4
1Department of Pediatric Surgery, University Children's Hospital Zurich, Zurich, Switzerland.
Background:
Fetal surgery for spina bifida aperta may lead to significantly better outcomes than postnatal repair, particularly regarding shunt-dependent hydrocephalus, independent ambulation, and voiding functions. The "Management of Myelomeningocele Study" (MOMS) represents the current benchmark, also in terms of eligibility criteria.
Case Report:
A positive maternal hepatitis B virus (HBV) status is a MOMS exclusion criterion. Here, we report on the first successful active and passive in utero HBV vaccination of a spina bifida fetus carried by a HBV-positive mother undergoing maternal-fetal surgery. The now 2-year-old infant is healthy, HBV negative, and drew maximal benefit from prenatal surgery.
Discussion And Conclusion:
Taken together, this patient benefitted maximally from fetal surgery for spina bifida, despite meeting an exclusion criterion. Thus, generally speaking, eligibility criteria for fetal surgery can be challenged under certain circumstances for the benefit of the patient.
